Role of Shwetari rasa and Savarnakara lepa in the management of Shwitra (Vitiligo)

Clinical evaluation of “Savarnakara Lepa ? and “Shwetari Rasa ? in the management of Shwitra with special reference to Vitiligo – A Randomized Control Trial.

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/052107

Enrollment

Registered

2023-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to participate in the clinical trial. 2. Patients in the age group of 18 to 60 years of either sex. 3. Patient diagnosed as Shwitra (vitiligo) on the basis of clinical features mentioned in Ayurveda texts. 4. Patient with history of Shwitra less than or equal to five years.

Exclusion criteria

Exclusion criteria: 1. Patient participated in any clinical trial within last six months. 2. White anesthetic spots, which are characteristic of leprosy. 3. Patches in genital area will be excluded from the study. 4. Vitiligo patches complicated with eczema, secondary bacterial infection. 5. Patients with evidence of malignancy, known case of diabetes mellitus, known case of hypertension , albinism and autoimmune disorders etc. 6. Pregnant women and lactating mother.

Design outcomes

Primary

Measure	Time frame
Assessment of changes in Vitiligo area & Severity index (VASI score). Timepoint: 60 days	—

Secondary

Measure	Time frame
To assess changes in LFT and RFT parameters.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Bhavya Khatri

National Institute of Ayurveda Deemed to be University

harishbhakuni78@gmail.com7891233108

Outcome results